This announcement is a separate document:
海思科:北京市中伦(深圳)律师事务所关于海思科医药集团股份有限公司2024年限制性股票激励计划的法律意见书
Haisco Pharmaceutical Group: Legal opinion of Zhong Lun (Shenzhen) Law Firm on Haisco Pharmaceutical Group Co., Ltd.'s 2024 restricted stock incentive plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.